← Leaderboards
John Jeffrey Talley
Sarmont, Llc
$1,958,828
Attributed
$6,603,977
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,603,977 · 7
By mechanism
R44$5,992,477 · 4
R43$386,500 · 2
R41$225,000 · 1
Top collaborators
- Christopher M Adams9 shared
- Scott Matthew Ebert9 shared
- Andrew Robert Judge2 shared
- Sarah M Judge2 shared
- Aleksey V Matveyenko1 shared
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadProgramsMedicineSafetyDesignMouse ModelMuscular AtrophyPharmacologic SubstanceMedicalAffectSeriesPharmaceutical PreparationsFda ApprovedChemistryLegal PatentSkeletal MuscleSmall Business Innovation Research GrantMrna ExpressionPreventStructure-Activity RelationshipPropertyQuality Of LifeMuscle FormDiabetes Mellitus
Grant awards (10)
Development of novel therapeutics for obesity and type 2 diabetes$1,021,719
R44 · FY2025 · DK
Development of novel therapeutics for cancer cachexia$997,245
R44 · FY2024 · CA
Development of novel therapeutics for cancer cachexia$990,411
R44 · FY2023 · CA
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy$745,404
R44 · FY2021 · AR
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy$745,404
R44 · FY2020 · AR
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy$746,147
R44 · FY2019 · AG
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy$746,147
R44 · FY2018 · AG
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy$225,000
R43 · FY2016 · AR
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy$225,000
R41 · FY2014 · AG
Controlled Release of Topical Nitric Oxide for Treating Cutaneous Injuries$161,500
R43 · FY2011 · GM · contact PI